These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4756131)

  • 21. [Tremor and motility following oxotremorine and harmine in rats with lesions of the nigro-striatal system].
    Westermann KH; Oelszner W; Staib AH; Funk K
    Acta Biol Med Ger; 1974; 33(1):67-76. PubMed ID: 4153886
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.
    Glowinski J
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():233-46. PubMed ID: 769114
    [No Abstract]   [Full Text] [Related]  

  • 23. Biochemical changes accompanying unilateral 6-hydroxydopamine lesions in the rat substantia nigra.
    Saavedra JM; Setler PE; Kebabian JW
    Brain Res; 1978 Aug; 151(2):339-52. PubMed ID: 679013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dopamine release in the rat nigrostratum system after hydroxy-5 tryptophan administration].
    Portmann-Cristesco EM; Boissier JR
    C R Acad Hebd Seances Acad Sci D; 1974 Feb; 278(7):963-5. PubMed ID: 4211396
    [No Abstract]   [Full Text] [Related]  

  • 25. Partial selectivity of 6-OHDA induced neuronal degeneration after intraissular injection in the brain with special reference to the nigro-striatal dopamine system.
    Javoy F
    J Neural Transm; 1975; 37(3):219-27. PubMed ID: 1185167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cerebral amines and behavior. Central effects of 6-hydroxydopamine].
    Longo VG; Scotti de Carolis A
    Actual Pharmacol (Paris); 1973; 26(0):103-19. PubMed ID: 4367113
    [No Abstract]   [Full Text] [Related]  

  • 27. Origin of various enzymes released from the substantia nigra and caudate nucleus: effects of 6-hydroxydopamine lesions of the nigro-striatal pathway.
    Greenfield SA; Grünewald RA; Foley P; Shaw SG
    J Comp Neurol; 1983 Feb; 214(1):87-92. PubMed ID: 6404955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Voltammetric analysis of nigral graft function.
    Hoffer BJ; Gerhardt GA; Rose GM; Strömberg I; Olson L
    Ann N Y Acad Sci; 1987; 495():510-27. PubMed ID: 3111328
    [No Abstract]   [Full Text] [Related]  

  • 29. Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra.
    Quik M; Emson PC; Joyce E
    Brain Res; 1979 May; 167(2):355-65. PubMed ID: 36204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The brain's dopamine receptor: labeling with (3H) dopamine and (3H) haloperidol.
    Snyder SH; Creese I; Burt DR
    Psychopharmacol Commun; 1975; 1(6):663-73. PubMed ID: 1241457
    [No Abstract]   [Full Text] [Related]  

  • 31. Localization of dopamine receptors in rat brain.
    Reisine TD; Nagy JI; Fibiger HC; Yamamura HI
    Brain Res; 1979 Jun; 169(1):209-14. PubMed ID: 455093
    [No Abstract]   [Full Text] [Related]  

  • 32. Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat.
    Agid Y; Javoy F; Glowinski J
    Nat New Biol; 1973 Oct; 245(144):150-1. PubMed ID: 4517903
    [No Abstract]   [Full Text] [Related]  

  • 33. Supersensitivity in rat caudate nucleus: effects of 6-hydroxydopamine on the time course of dopamine receptor and cyclic AMP changes.
    Mishra RK; Marshall AM; Varmuza SL
    Brain Res; 1980 Oct; 200(1):47-57. PubMed ID: 6251945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catalepsy and circling behaviour after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain.
    Costall B; Naylor RJ; Olley JE
    Neuropharmacology; 1972 Sep; 11(5):645-63. PubMed ID: 4597256
    [No Abstract]   [Full Text] [Related]  

  • 35. Degeneration of the nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatum.
    Ichitani Y; Okamura H; Matsumoto Y; Nagatsu I; Ibata Y
    Brain Res; 1991 May; 549(2):350-3. PubMed ID: 1679369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats.
    Robertson GS; Fine A; Robertson HA
    Brain Res; 1991 Jan; 539(2):304-11. PubMed ID: 1675908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spontaneous recovery from motor asymmetry in adult rats with 6-hydroxydopamine-induced partial lesions of the substantia nigra.
    Dravid A; Jaton AL; Enz A; Frei P
    Brain Res; 1984 Oct; 311(2):361-5. PubMed ID: 6149789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substantia nigra 6-hydroxydopamine lesions alter dopaminergic synaptic markers in the nucleus basalis magnocellularis and striatum of rats.
    Geula C; Slevin JT
    Synapse; 1989; 4(3):248-53. PubMed ID: 2532792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demonstration of the nigrostriatal projection by silver staining after nigral injections of 6-hydroxydopamine.
    Maler L; Fibiger HC; McGeer PL
    Exp Neurol; 1973 Aug; 40(2):505-15. PubMed ID: 4125858
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.